NICOLE MANGETT
- Type
- Non-physician practitioner · Physician Assistants & Advanced Practice Nursing Providers / Nurse Practitioner
- Where
- CLIO, MI
- NPI
- 1710589585
- Received
- $2,707 in 130 records, 2021 to 2025
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 62 | $1,172 |
| 2024 | General payment | 36 | $674 |
| 2023 | General payment | 28 | $607 |
| 2022 | General payment | 3 | $174 |
| 2021 | General payment | 1 | $77 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| ABBVIE INC. | 47 | $613 | 2023–2025 |
| GlaxoSmithKline, LLC. | 15 | $577 | 2021–2025 |
| Vanda Pharmaceuticals Inc. | 11 | $295 | 2025 |
| Otsuka America Pharmaceutical, Inc. | 8 | $176 | 2023–2025 |
| Neurocrine BioSciences, Inc. | 3 | $138 | 2023 |
| Teva Pharmaceuticals USA, Inc. | 4 | $126 | 2024–2025 |
| AstraZeneca Pharmaceuticals LP | 8 | $123 | 2023–2025 |
| Axsome Therapeutics, Inc. | 5 | $114 | 2023–2025 |
| Novo Nordisk Inc | 5 | $91 | 2024–2025 |
| Exact Sciences Corporation | 3 | $85 | 2023–2025 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $61 | 2023–2025 |
| PFIZER INC. | 3 | $52 | 2024–2025 |
| Janssen Pharmaceuticals, Inc | 3 | $48 | 2023–2024 |
| Amgen Inc. | 2 | $38 | 2024–2025 |
| E.R. Squibb & Sons, L.L.C. | 2 | $34 | 2025 |
| Organon Llc | 1 | $20 | 2024 |
| SANOFI PASTEUR INC. | 1 | $20 | 2022 |
| Alnylam Pharmaceuticals Inc. | 1 | $19 | 2024 |
| Alexion Pharmaceuticals, Inc. | 1 | $18 | 2025 |
| Merck Sharp & Dohme LLC | 1 | $17 | 2024 |
| Lilly USA, LLC | 1 | $17 | 2024 |
| Cipher Pharmaceuticals US LLC | 1 | $15 | 2025 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Food and Beverage | 130 | $2,707 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-17 | Teva Pharmaceuticals USA, Inc. | $16 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-12-12 | ABBVIE INC. | $5 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-12-10 | Otsuka America Pharmaceutical, Inc. | $23 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-12-10 | Vanda Pharmaceuticals Inc. | $22 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-12-04 | Amgen Inc. | $19 | Food and Beverage | In-kind items and services | REPATHA Biological, Cardiovascular | 2025 | |
| 2025-12-03 | ABBVIE INC. | $12 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-11-20 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-11-19 | Vanda Pharmaceuticals Inc. | $39 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-11-13 | GlaxoSmithKline, LLC. | $14 | Food and Beverage | In-kind items and services | AREXVY Biological, RESPIRATORY | 2025 | |
| 2025-11-12 | Vanda Pharmaceuticals Inc. | $29 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-11-09 | Novo Nordisk Inc | $18 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-11-06 | ABBVIE INC. | $5 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-11-05 | E.R. Squibb & Sons, L.L.C. | $18 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-29 | Otsuka America Pharmaceutical, Inc. | $24 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-10-29 | AstraZeneca Pharmaceuticals LP | $17 | Food and Beverage | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2025 | |
| 2025-10-23 | Otsuka America Pharmaceutical, Inc. | $12 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-10-22 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-10-16 | PFIZER INC. | $17 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-10-15 | GlaxoSmithKline, LLC. | $17 | Food and Beverage | In-kind items and services | TRELEGY ELLIPTA Drug, RESPIRATORY | 2025 | |
| 2025-10-15 | Vanda Pharmaceuticals Inc. | $16 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-10-08 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-10-02 | Exact Sciences Corporation | $26 | Food and Beverage | In-kind items and services | The Cologuard Plus Collection Kit Device, Oncology | 2025 | |
| 2025-09-18 | Novo Nordisk Inc | $22 | Food and Beverage | In-kind items and services | Rybelsus Drug, Diabetes | 2025 | |
| 2025-09-18 | ABBVIE INC. | $1 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-09-17 | Vanda Pharmaceuticals Inc. | $21 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-09-16 | Axsome Therapeutics, Inc. | $28 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-09-04 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $17 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-08-28 | Alexion Pharmaceuticals, Inc. | $18 | Food and Beverage | In-kind items and services | STRENSIQ Biological, Rare Disease | 2025 | |
| 2025-08-27 | Vanda Pharmaceuticals Inc. | $38 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-08-21 | PFIZER INC. | $18 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-08-20 | Axsome Therapeutics, Inc. | $26 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-20 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $13 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-08-07 | Teva Pharmaceuticals USA, Inc. | $17 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-08-06 | Vanda Pharmaceuticals Inc. | $23 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-08-01 | Novo Nordisk Inc | $14 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-07-31 | Cipher Pharmaceuticals US LLC | $15 | Food and Beverage | Cash or cash equivalent | Natroba Drug, Antiparasitic | 2025 | |
| 2025-07-31 | ABBVIE INC. | $7 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-07-23 | Otsuka America Pharmaceutical, Inc. | $31 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-07-16 | Vanda Pharmaceuticals Inc. | $31 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-07-10 | ABBVIE INC. | $10 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-06-27 | ABBVIE INC. | $15 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2025 | |
| 2025-06-25 | Vanda Pharmaceuticals Inc. | $28 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-06-12 | ABBVIE INC. | $7 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-06-05 | Exact Sciences Corporation | $26 | Food and Beverage | In-kind items and services | The Cologuard Plus Collection Kit Device, Oncology | 2025 | |
| 2025-06-04 | Axsome Therapeutics, Inc. | $22 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-05-28 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-05-21 | Otsuka America Pharmaceutical, Inc. | $24 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-05-21 | Vanda Pharmaceuticals Inc. | $21 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-05-14 | ABBVIE INC. | $3 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-05-06 | ABBVIE INC. | $80 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-05-02 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-04-28 | GlaxoSmithKline, LLC. | $20 | Food and Beverage | In-kind items and services | TRELEGY ELLIPTA Drug, RESPIRATORY | 2025 | |
| 2025-04-25 | Novo Nordisk Inc | $15 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-04-21 | ABBVIE INC. | $6 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-04-08 | ABBVIE INC. | $4 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-04-02 | E.R. Squibb & Sons, L.L.C. | $16 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-03-26 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2025 | |
| 2025-03-04 | ABBVIE INC. | $4 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-02-26 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-02-19 | Otsuka America Pharmaceutical, Inc. | $21 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-02-18 | Vanda Pharmaceuticals Inc. | $22 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-02-06 | Teva Pharmaceuticals USA, Inc. | $20 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2024-11-21 | Lilly USA, LLC | $17 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2024 | |
| 2024-11-14 | GlaxoSmithKline, LLC. | $117 | Food and Beverage | In-kind items and services | AREXVY Drug, RESPIRATORY | 2024 | |
| 2024-10-31 | GlaxoSmithKline, LLC. | $8 | Food and Beverage | In-kind items and services | AREXVY Drug, RESPIRATORY | 2024 | |
| 2024-10-29 | Novo Nordisk Inc | $20 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2024 | |
| 2024-10-22 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-10-17 | GlaxoSmithKline, LLC. | $6 | Food and Beverage | In-kind items and services | TRELEGY ELLIPTA Drug, RESPIRATORY | 2024 | |
| 2024-08-27 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-08-21 | Teva Pharmaceuticals USA, Inc. | $71 | Food and Beverage | In-kind items and services | Austedo XR Drug, Central Nervous System | 2024 | |
| 2024-07-30 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $14 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-07-15 | ABBVIE INC. | $4 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-07-03 | GlaxoSmithKline, LLC. | $14 | Food and Beverage | In-kind items and services | TRELEGY ELLIPTA Drug, RESPIRATORY | 2024 | |
| 2024-06-25 | AstraZeneca Pharmaceuticals LP | $14 | Food and Beverage | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2024 | |
| 2024-06-17 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-06-12 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2024 | |
| 2024-06-11 | ABBVIE INC. | $3 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-06-03 | ABBVIE INC. | $2 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-05-23 | ABBVIE INC. | $15 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-05-16 | Organon Llc | $20 | Food and Beverage | In-kind items and services | NEXPLANON Drug, ETONOGESTREL | 2024 | |
| 2024-05-09 | Merck Sharp & Dohme LLC | $17 | Food and Beverage | In-kind items and services | GARDASIL Biological, VACCINE | 2024 | |
| 2024-04-24 | ABBVIE INC. | $80 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-04-23 | PFIZER INC. | $16 | Food and Beverage | In-kind items and services | PREVNAR 20 Biological, VACCINES | 2024 | |
| 2024-04-23 | ABBVIE INC. | $2 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-04-16 | GlaxoSmithKline, LLC. | $13 | Food and Beverage | In-kind items and services | TRELEGY ELLIPTA Drug, RESPIRATORY | 2024 | |
| 2024-04-11 | ABBVIE INC. | $20 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-03-07 | Amgen Inc. | $19 | Food and Beverage | In-kind items and services | Otezla Drug, Inflammation | 2024 | |
| 2024-03-04 | ABBVIE INC. | $3 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-02-27 | AstraZeneca Pharmaceuticals LP | $16 | Food and Beverage | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2024 | |
| 2024-02-26 | ABBVIE INC. | $1 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-02-05 | ABBVIE INC. | $3 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-01-30 | AstraZeneca Pharmaceuticals LP | $16 | Food and Beverage | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2024 | |
| 2024-01-26 | Alnylam Pharmaceuticals Inc. | $19 | Food and Beverage | In-kind items and services | GIVLAARI Drug, Genetic Disease | 2024 | |
| 2024-01-22 | ABBVIE INC. | $2 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-01-18 | Otsuka America Pharmaceutical, Inc. | $16 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-01-16 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2024 | |
| 2024-01-11 | Janssen Pharmaceuticals, Inc | $18 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2024 | |
| 2024-01-04 | GlaxoSmithKline, LLC. | $14 | Food and Beverage | In-kind items and services | BEXSERO Biological, VACCINES | 2024 | |
| 2023-12-11 | ABBVIE INC. | $1 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-12-04 | ABBVIE INC. | $1 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-11-30 | ABBVIE INC. | $22 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-11-29 | ABBVIE INC. | $76 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-11-29 | ABBVIE INC. | $15 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2023 | |
| 2023-11-16 | AstraZeneca Pharmaceuticals LP | $14 | Food and Beverage | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2023 | |
| 2023-11-16 | ABBVIE INC. | $2 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-10-31 | Axsome Therapeutics, Inc. | $18 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2023 | |
| 2023-10-30 | ABBVIE INC. | $1 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-10-27 | Janssen Pharmaceuticals, Inc | $14 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2023 | |
| 2023-10-22 | AstraZeneca Pharmaceuticals LP | $15 | Food and Beverage | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2023 | |
| 2023-10-20 | GlaxoSmithKline, LLC. | $14 | Food and Beverage | In-kind items and services | TRELEGY ELLIPTA Drug, RESPIRATORY | 2023 | |
| 2023-10-12 | Exact Sciences Corporation | $32 | Food and Beverage | In-kind items and services | Cologuard Collection Kit Device, Oncology | 2023 | |
| 2023-09-27 | Neurocrine BioSciences, Inc. | $126 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2023 | |
| 2023-09-19 | AstraZeneca Pharmaceuticals LP | $14 | Food and Beverage | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2023 | |
| 2023-09-14 | Janssen Pharmaceuticals, Inc | $15 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2023 | |
| 2023-09-13 | ABBVIE INC. | $6 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-09-12 | Axsome Therapeutics, Inc. | $18 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2023 | |
| 2023-08-22 | GlaxoSmithKline, LLC. | $13 | Food and Beverage | In-kind items and services | TRELEGY ELLIPTA Drug, RESPIRATORY | 2023 | |
| 2023-08-16 | Otsuka America Pharmaceutical, Inc. | $22 | Food and Beverage | In-kind items and services | ABILIFY ASIMTUFII Drug, PSYCHIATRY | 2023 | |
| 2023-08-15 | Neurocrine BioSciences, Inc. | $12 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2023 | |
| 2023-08-15 | Neurocrine BioSciences, Inc. | $0 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2023 | |
| 2023-08-14 | ABBVIE INC. | $2 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-08-03 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $16 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-07-29 | AstraZeneca Pharmaceuticals LP | $13 | Food and Beverage | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2023 | |
| 2023-07-21 | ABBVIE INC. | $3 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-07-20 | ABBVIE INC. | $21 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-03-08 | GlaxoSmithKline, LLC. | $89 | Food and Beverage | In-kind items and services | 2023 | ||
| 2022-11-17 | GlaxoSmithKline, LLC. | $91 | Food and Beverage | In-kind items and services | 2022 | ||
| 2022-09-01 | SANOFI PASTEUR INC. | $20 | Food and Beverage | In-kind items and services | MENQUADFI Biological, Vaccines | 2022 | |
| 2022-03-29 | GlaxoSmithKline, LLC. | $63 | Food and Beverage | In-kind items and services | TRELEGY ELLIPTA Drug, RESPIRATORY | 2022 | |
| 2021-11-17 | GlaxoSmithKline, LLC. | $77 | Food and Beverage | In-kind items and services | TRELEGY ELLIPTA Drug, RESPIRATORY | 2021 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Clio, MI, county Genesee County, MI, state Michigan; placed by its city name.
| Measure | Place (city or town) Clio, MI | County Genesee County, MI | State Michigan |
|---|---|---|---|
| Population B01003 | 2,185 | 403,305 | 10,077,761 |
| Population, 2020 census P1 | 2,525 | 406,211 | 10,077,331 |
| Median age B01002 | 47.9 | 40.6 | 40.2 |
| Under 18 B01001 | 19.5% | 22.2% | 21.2% |
| 65 and over B01001 | 23.5% | 18.8% | 18.6% |
| Households B11001 | 1,176 | 167,334 | 4,076,369 |
| Foreign born B05002 | 1.2% | 2.9% | 7.2% |
| Median household income B19013 | $52,500 | $62,281 | $72,875 |
| Median family income B19113 | $73,080 | $78,441 | $93,357 |
| Per capita income B19301 | $30,963 | $35,334 | $40,735 |
| Poverty rate B17001 | 20.0% | 16.4% | 13.2% |
| Unemployment rate B23025 | 4.2% | 8.1% | 5.7% |
| Civilian labor force B23025 | 1,163 | 189,612 | 5,018,449 |
| Mean commute (minutes) B08013 | 33.0 | 26.9 | 24.2 |
| Bachelor's degree or higher B15003 | 23.1% | 23.3% | 32.4% |
| Housing units B25001 | 1,207 | 183,903 | 4,622,236 |
| Owner-occupied B25003 | 54.5% | 70.7% | 73.2% |
| Renters B25003 | 45.5% | 29.3% | 26.8% |
| Median home value B25077 | $138,200 | $182,400 | $231,600 |
| Median gross rent B25064 | $790 | $989 | $1,129 |
| White, not Hispanic B03002 | 93.7% | 70.0% | 72.4% |
| Black B03002 | 1.2% | 19.1% | 13.1% |
| Hispanic or Latino B03002 | 2.4% | 4.3% | 5.9% |
| Asian B03002 | 1.2% | 1.1% | 3.4% |
| American Indian and Alaska Native B03002 | 0.0% | 0.2% | 0.3% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Clio, MI.
Comments